Fate Therapeutics

Fate Therapeutics is a clinical-stage biopharmaceutical company that pioneers off-the-shelf, programmed cellular immunotherapies derived from clonal master induced pluripotent stem cell lines. The enterprise manufactures universal natural killer and T-cell therapies engineered to attack hematologic cancers, solid tumors, and severe autoimmune diseases without requiring donor-derived harvesting. By advancing scalable iPSC cell manufacturing, Fate Therapeutics aims to deliver uniform, cost-effective cellular medicines.